Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 9, 2011

Drug Name	Review Type	Class	Manufacturer
Pradaxa	New Drug Initial Review	Direct Thrombin Inhibitor	Boehringer Ingelheim
Veregen	New Drug Initial Review	Topical Genital Wart � HPV Treatment Agent	PharmaDerm
Latuda	New Drug Initial Review	Antipsychotic	Sunovion
Kapvay	New Drug Initial Review	Alpha-2 Adrenergic Agent	Shionogi Pharma
Fanapt	New Drug Appeal	Atypical Antipsychotic	Novartis
Pegasys	PDL Appeal	Hepatitis B and C Agent	Genentech

Footer